EZM0414 is a potent, selective, oral bioavailable SETD2 inhibitor (IN SETD2 biochemical analysis, IC50=18 nM, In cell analysis, IC50=34 nM). EZM0414 can be used to study relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma.
Molecular Weight:
400.49
Purity:
>99.0%
CAS Number:
[2411748-50-8]
Formula:
C22H29FN4O2
Target:
Histone Methyltransferase
* VAT and and shipping costs not included. Errors and price changes excepted